# Interpectoral-pectoserratus Plane Block for Minimally Invasive Aortic Valve Replacement Via Right Anterior Minithoracotomy

> **NCT06369870** · PHASE4 · RECRUITING · sponsor: **Algemeen Ziekenhuis Maria Middelares** · enrollment: 144 (estimated)

## Conditions studied

- Analgesic Effect

## Interventions

- **DRUG:** Levobupivacaine Hydrochloride 0.25 % Injectable Solution
- **DRUG:** Sodium chloride 0.9%

## Key facts

- **NCT ID:** NCT06369870
- **Lead sponsor:** Algemeen Ziekenhuis Maria Middelares
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-01
- **Primary completion:** 2027-11
- **Final completion:** 2027-12
- **Target enrollment:** 144 (ESTIMATED)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06369870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06369870, "Interpectoral-pectoserratus Plane Block for Minimally Invasive Aortic Valve Replacement Via Right Anterior Minithoracotomy". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06369870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*